Jamison, R. N. & Mao, J. Opioid analgesics. Mayo Clin. Proc. 90, 957–968 (2015).
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A. & Gladden, R. M. Deaths involving fentanyl, fentanyl analogs, and U-47700—10 states, July–December 2016. MMWR Morb. Mortal. Wkly Rep. 66, 1197–1202 (2017).
Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb. Mortal. Wkly Rep. 60, 1487–1492 (2011).
Rudd, R. A. et al. Increases in heroin overdose deaths—28 states, 2010 to 2012. MMWR Morb. Mortal. Wkly Rep. 63, 849–854 (2014).
National Academies of Sciences, Engineering, and Medicine. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (National Academies Press, 2017).
Abdelal, R. et al. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Harm. Reduct. J. 19, 49 (2022).
Thompson, G. L. et al. Biased agonism of endogenous opioid peptides at the μ-opioid receptor. Mol. Pharmacol. 88, 335–346 (2015).
Benarroch, E. E. Endogenous opioid systems: current concepts and clinical correlations. Neurology 79, 807–814 (2012).
De Neve, J. et al. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors. RSC Med. Chem. 12, 828–870 (2021).
Wang, Y. et al. Structures of the entire human opioid receptor family. Cell https://doi.org/10.1016/j.cell.2022.12.026 (2023).
Rasmussen, K., White, D. A. & Acri, J. B. NIDA’s medication development priorities in response to the opioid crisis: ten most wanted. Neuropsychopharmacology 44, 657–659 (2019).
Faouzi, A. et al. Structure-based design of bitopic ligands for the µ-opioid receptor. Nature 613, 767–774 (2023).
Bueno, A. B. et al. Structural insights into probe-dependent positive allosterism of the GLP-1 receptor. Nat. Chem. Biol. 16, 1105–1110 (2020).
Vaysse, P. J.-J., Gardner, E. L. & Zukin, S. Modulation of rat brain opioid receptors by cannabinoids. J. Pharmacol. Exp. Ther. 241, 534–539 (1987).
Rothman, R. B. et al. Salvinorin A: allosteric interactions at the μ-opioid receptor. J. Pharmacol. Exp. Ther. 320, 801–810 (2007).
Franzini, R. M. & Randolph, C. Chemical space of DNA-encoded libraries: miniperspective. J. Med. Chem. 59, 6629–6644 (2016).
Halford, B. How DNA-encoded libraries are revolutionizing drug discovery. Chemical & Engineering News (19 June 2017).
Gironda-Martínez, A., Donckele, E. J., Samain, F. & Neri, D. DNA-encoded chemical libraries: a comprehensive review with succesful stories and future challenges. ACS Pharmacol. Transl. Sci. 4, 1265–1279 (2021).
Ahn, S. et al. Small-molecule positive allosteric modulators of the β2-adrenoceptor isolated from DNA-encoded libraries. Mol. Pharmacol. 94, 850–861 (2018).
Ahn, S. et al. Allosteric “beta-blocker” isolated from a DNA-encoded small molecule library. Proc. Natl Acad. Sci. USA 114, 1708–1713 (2017).
Liu, X. et al. Mechanism of intracellular allosteric β2AR antagonist revealed by X-ray crystal structure. Nature 548, 480–484 (2017).
Liu, X. et al. Mechanism of β2 AR regulation by an intracellular positive allosteric modulator. Science 364, 1283–1287 (2019).
Gregorio, G. G. et al. Single-molecule analysis of ligand efficacy in β2AR–G-protein activation. Nature 547, 68–73 (2017).
Hilger, D. et al. Structural insights into differences in G protein activation by family A and family B GPCRs. Science 369, eaba3373 (2020).
Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841–849 (2020).
Livingston, K. E. & Traynor, J. R. Allostery at opioid receptors: modulation with small molecule ligands. Br. J. Pharmacol. 175, 2846–2856 (2018).
Che, T. et al. Structure of the nanobody-stabilized active state of the kappa opioid receptor. Cell 172, 55–67.e15 (2018).
Che, T. et al. Nanobody-enabled monitoring of kappa opioid receptor states. Nat. Commun. 11, 1145 (2020).
Robertson, M. J. et al. Structure determination of inactive-state GPCRs with a universal nanobody. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-022-00859-8 (2022).
Manglik, A. et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 485, 321–326 (2012).
Huang, W. et al. Structural insights into μ-opioid receptor activation. Nature 524, 315–321 (2015).
Koehl, A. et al. Structure of the µ opioid receptor–Gi protein complex. Nature 558, 547–552 (2018).
Váradi, A. et al. Mitragynine/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit β-arrestin-2. J. Med. Chem. 59, 8381–8397 (2016).
Smits, S. E. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice. Res. Commun. Chem. Pathol. Pharmacol. 15, 689–696 (1976).
Bloom, A. S., Dewey, W. L., Harris, L. S. & Brosius, K. K. The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail-flick test and increased synthesis of brain catecholamines. J. Pharmacol. Exp. Ther. 198, 33–41 (1976).
Székely, J. I., Dunai-Kovács, Z., Miglécz, E., Rónai, A. Z. & Bajusz, S. In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog. J. Pharmacol. Exp. Ther. 207, 878–883 (1978).
Chakraborty, S. et al. Oxidative metabolism as a modulator of kratom’s biological actions. J. Med. Chem. 64, 16553–16572 (2021).
Wilson, L. L. et al. Lyophilized kratom tea as a therapeutic option for opioid dependence. Drug Alcohol Depend. 216, 108310–108318 (2020).
Wilson, L. L. et al. Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal. Cell. Mol. Neurobiol. 41, 1131–1143 (2021).
Kandasamy, R. et al. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects. Proc. Natl Acad. Sci. USA 118, e2000017118 (2021).
Draper-Joyce, C. J. et al. Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia. Nature 597, 571–576 (2021).
Slosky, L. M. et al. β-arrestin-biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors. Cell 181, 1364–1379.e14 (2020).
Persechino, M., Hedderich, J. B., Kolb, P. & Hilger, D. Allosteric modulation of GPCRs: from structural insights to in silico drug discovery. Pharmacol. Ther. 237, 108242 (2022).
Krumm, B. E. et al. Neurotensin receptor allosterism revealed in complex with a biased allosteric modulator. Biochemistry 62, 1233–1248 (2023).
Cong, Z. et al. Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. Nat. Commun. 12, 3763 (2021).
Xu, J. et al. Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor. Nat. Commun. 14, 376 (2023).
Hedderich, J. B. et al. The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites. Nat. Commun. 13, 2567 (2022).
Kumar, K. K. et al. Structure of a signaling cannabinoid receptor 1–G protein complex. Cell https://doi.org/10.1016/j.cell.2018.11.040 (2019).
Wang, H. et al. Structure-based evolution of G protein-biased μ-opioid receptor agonists. Angew. Chem. Int. Ed. https://doi.org/10.1002/anie.202200269 (2022).
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 65, 1074–1080 (2009).
Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94–106 (2011).
Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859–1865 (2008).
Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997–2004 (2014).
Jo, S., Lim, J. B., Klauda, J. B. & Im, W. CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. Biophys. J. 97, 50–58 (2009).
Jo, S., Kim, T. & Im, W. Automated builder and database of protein/membrane complexes for molecular dynamics simulations. PLoS ONE 2, e880 (2007).
Lee, J. et al. CHARMM-GUI Membrane Builder for complex biological membrane simulations with glycolipids and lipoglycans. J. Chem. Theory Comput. 15, 775–786 (2019).
Yu, W., He, X., Vanommeslaeghe, K. & Mackerell, A. D. Jr. Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. J. Comput. Chem. 33, 2451–2468 (2012).
Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671–690 (2009).
Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017).
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
Eastman, P. et al. OpenMM 7: rapid development of high performance algorithms for molecular dynamics. PLoS Comput. Biol. 13, e1005659 (2017).
Hopkins, C. W., Le Grand, S., Walker, R. C. & Roitberg, A. E. Long-time-step molecular dynamics through hydrogen mass repartitioning. J. Chem. Theory Comput. 11, 1864–1874 (2015).
Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327–341 (1977).
Michaud-Agrawal, N., Denning, E. J., Woolf, T. B. & Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 32, 2319–2327 (2011).
Gowers, R. J. et al. MDAnalysis: a Python package for the rapid analysis of molecular dynamics simulations. In Proc. 15th Python in Science Conference (eds Benthall, S. & Rostrup, S.) 98–105 (SciPy, 2016).
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Animals 4, 35–44 (2014).
Chakraborty, S. et al. A novel mitragynine analog with low-efficacy mu opioid receptor agonism displays antinociception with attenuated adverse effects. J. Med. Chem. 64, 13873–13892 (2021).
Wilson, L. L. et al. Characterization of CM-398, a novel selective sigma-2 receptor ligand, as a potential therapeutic for neuropathic pain. Molecules 27, 3617 (2022).
Uprety, R. et al. Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site. eLife 10, e56519 (2021).
Reilley, K. J. et al. Identification of two novel, potent, low-liability antinociceptive compounds from the direct in vivo screening of a large mixture-based combinatorial library. AAPS J. 12, 318–329 (2010).
Brice-Tutt, A. C. et al. Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour. Br. J. Pharmacol. 177, 4209–4222 (2020).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
